Hester Biosciences Share Price

Hester Biosciences Share Price

NSE: HESTERBIO
|
Pharmaceuticals
|
S Cap
₹ 2,262.00
-₹17.00 (-0.75%)
1D
Last updated 11 Sep, 2026, 15:29 IST

Hester Biosciences Share Price Today

As of 11 Sep 2026, Hester Biosciences share price is ₹2,262.00. The stock opened at ₹2,275.00, compared to its previous close of ₹2,279.00. During today's trading session, Hester Biosciences share price moved in the range of ₹2,238.30 to ₹2,298.90, with an average price of ₹2,268.60 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,239.30 and a high of ₹2,683.60. On the performance front, Hester Biosciences share price has increased by 57.65% over the last six months and is up 8.51% on a year-on-year basis.

₹2,238.30
0.75% down today
₹2,298.90
1D LOW
1D HIGH

Hester Biosciences Returns Calculator

Circuit
L
H
₹1,823.20
₹2,734.80
52-week
L
H
₹1,239.30
₹2,683.60

About Hester Biosciences

Hester Biosciences Share Price
ISIN
INE782E01017
Sector Market Cap
₹ 1,954.28 Cr

Hester Biosciences Limited is an India-based animal healthcare company. The Company is principally engaged in manufacturing poultry vaccines, large animal vaccines, and trading poultry, large animal, and petcare health products. It operates through three segments: Poultry Healthcare, Animal Healthcare, and Petcare. The Poultry Healthcare vaccines include Gumboro I, Inactivated Chick ND, Inactivated Coryza, Inactivated EDS, Inactivated FC3, Inactivated FC4, Inactivated IB, and Inactivated IBD. The Animal Healthcare vaccines include Goat Pox Vaccine, Live Brucella, PPR Vaccine - Nigerian 75/1, and PPR Vaccine - Sungri/96. Its Petcare products include Cefshot Tazo Injection, Hestacef CV, Hestacef DS, Pawfresh, Synoton, Petsglow, and Vitacoat. The Company also operates diagnostic labs for poultry and provides diagnostic kits for sero-surveillance and mastitis prevention for cattle farms. Its manufacturing facility is located at Meda Adraj Village, Mehsana District, Gujarat.

Hester Biosciences Financial Highlights

  • Revenue: Hester Biosciences reported revenue of ₹342.28 crore in FY26 vs ₹315.02 crore in FY25. It showed an increase of 8.65% on a yearly basis.
  • Operating Profit: Hester Biosciences reported an operating profit of ₹75.84 crore in FY26 vs ₹39.57 crore in FY25. It showed an increase of 91.66% on a year-on-year basis.
  • Net Profit: Hester Biosciences reported a net profit of ₹57.48 crore in FY26 vs ₹28.83 crore in FY25. It showed an increase of 99.38% on a yearly basis.

Hester Biosciences Quarterly Result Highlights

  • Hester Biosciences reported revenue of ₹78.88 crore in Jun 2026, compared with ₹97.08 crore in Mar 2026, representing a decrease of 18.75% on a quarter-on-quarter (QoQ) basis.
  • Hester Biosciences reported an operating profit of ₹101.68 crore in Jun 2026, compared with ₹25.09 crore in Mar 2026, representing an increase of 305.26% on a quarter-on-quarter (QoQ) basis.
  • Hester Biosciences reported a profit of ₹96.73 crore in Jun 2026, compared with ₹16.55 crore in Mar 2026, reflecting an increase of 484.47% on a QoQ basis.
  • The earnings per share (EPS) of Hester Biosciences stood at ₹67.57 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
53.73%
FII
0.31%
Other DII
0.00%
Retail and other
45.95%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.53%
Dec 20250.51%
Mar 20260.38%
Jun 20260.31%
Mkt Cap Cr
1,954.28
P/E
14.27
P/B
5.43
ROE
15.45%
D/E
0.19
ROCE
14.34%
Div. Yield
0.48%
EPS(TTM)
61.24
Turnover
0.54
EV/EBITDA
11.31
Net Margin
17.83%
Op. Margin
29.81%
ROA
20.20%
Quick Ratio
1.41
Curr. Ratio
4.86
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Hester Bios has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Hester Bios appears overvalued compared to its peers
Step 5 of 5
Earnings
Excellent
Hester Bios revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,47,236.0036.915.3513.74%0.6117.33%93.240.86%0.4810.90
Divis Laboratories2,49,673.0085.3614.9015.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,87,460.0086.9522.2925.49%1.6913.85%222.760.69%0.4958.70
Zydus Lifesciences1,11,521.0024.284.1118.59%0.3117.35%237.300.09%0.3335.38
Cipla1,11,484.0033.223.2411.27%0.0014.95%423.360.94%0.4543.52
Laurus Labs1,04,604.0095.9419.7416.77%0.4016.14%97.200.10%0.6713.72
Aurobindo Pharma96,030.6025.882.539.25%0.1911.76%394.820.24%0.3841.58
Lupin94,882.7017.094.2323.76%0.0424.88%659.000.87%0.57129.18
Dr. Reddy's Laboratories95,220.3029.912.5011.07%0.1812.54%377.950.70%0.4138.68
Mankind Pharma92,769.9044.875.6911.74%0.3413.13%396.980.04%0.4449.37

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Hester Biosciences Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹332.60₹311.10₹304.55₹266.09
Other Income₹9.68₹3.92₹10.64₹15.15
Total Revenue₹342.28₹315.03₹315.18₹281.24
Total Expenses₹275.76₹279.56₹287.84₹245.50
Profit Before Tax₹75.84₹39.57₹31.95₹40.15
Tax₹18.35₹10.75₹10.79₹12.12
Profit After Tax₹57.48₹28.83₹21.17₹28.04
EPS - Basic₹67.57₹33.89₹24.88₹31.30
EPS - Diluted₹67.57₹33.89₹24.88₹31.30

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹75.84₹39.57₹31.95₹40.15
Income before WC changes₹109.41₹66.04₹56.18₹52.54
Change in Assets-₹31.40₹8.34₹13.06-₹42.13
Change in Liabilities₹0.26₹1.60-₹9.38₹21.29
Change in WC-₹31.15₹9.95₹3.67-₹20.84
Cash flow from Operations₹64.14₹64.51₹48.18₹23.60
Cash flow from Investing-₹2.87-₹19.00-₹22.61-₹77.00
Cash flow from Financing-₹48.79-₹51.72-₹26.09₹41.76
Total Cash Flow-₹2.82-₹6.72-₹0.36-₹11.59
Cash (Start of the year)₹5.59₹12.31₹12.67₹24.75
Cash (End of the year)₹2.77₹5.59₹12.31₹13.16

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹469.38₹458.21₹447.73₹442.37
Current Assets₹208.56₹195.17₹214.62₹227.59
Total Assets₹677.94₹653.39₹662.35₹669.97
Current Liabilities₹152.48₹125.18₹105.47₹148.70
Net Current Asset₹56.08₹69.99₹109.14₹78.90
Non-Current Liabilities₹157.67₹201.55₹254.00₹232.72
Equity Capital₹367.79₹326.66₹302.88₹288.55
Total Equity & Liabilities₹677.94₹653.39₹662.35₹669.97

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹292.14₹286.47₹285.16₹254.00
Other Income₹7.64₹4.76₹4.26₹5.32
Total Revenue₹299.77₹291.23₹289.42₹259.32
Total Expenses₹237.09₹249.47₹252.69₹215.40
Profit Before Tax₹69.68₹41.76₹36.73₹43.92
Tax₹17.58₹9.92₹9.57₹11.58
Profit After Tax₹52.10₹31.84₹27.16₹32.34
EPS - Basic₹61.24₹37.43₹31.93₹38.02
EPS - Diluted₹61.24₹37.43₹31.93₹38.02

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹69.68₹41.76₹36.73₹43.92
Income before WC changes₹81.91₹57.58₹50.06₹58.48
Change in Assets-₹10.86₹13.04₹10.16-₹44.32
Change in Liabilities-₹6.64₹3.27-₹6.33₹27.27
Change in WC-₹17.50₹16.31₹3.84-₹17.05
Cash flow from Operations₹50.92₹63.97₹42.86₹33.36
Cash flow from Investing-₹2.36-₹19.04-₹20.59-₹71.96
Cash flow from Financing-₹48.31-₹46.35-₹24.12₹41.38
Total Cash Flow₹0.25-₹1.42-₹1.85₹2.77
Cash (Start of the year)₹0.55₹1.97₹3.81₹1.53
Cash (End of the year)₹0.79₹0.55₹1.97₹4.30

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹367.58₹360.76₹345.13₹329.77
Current Assets₹189.76₹185.24₹204.41₹216.05
Total Assets₹557.35₹546.00₹549.55₹545.82
Current Liabilities₹91.92₹96.70₹97.72₹136.47
Net Current Asset₹97.85₹88.53₹106.69₹79.58
Non-Current Liabilities₹80.25₹110.21₹139.11₹116.96
Equity Capital₹385.18₹339.09₹312.71₹292.38
Total Equity & Liabilities₹557.35₹546.00₹549.55₹545.82
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 0
Buy orders: 0%
Sell orders: 0%
Bearish
2
Neutral
6
Bullish
0
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
45.11
Neutral
ATR (14)
95.53
Neutral
STOCH(9,6)
33.68
Neutral
STOCH RSI (14)
55.72
Neutral
ADX(9)
26.76
Bearish
UO(9)
48.48
Neutral
ROC(12)
-5.9
Bearish
WillR(14)
-66.32
Neutral
Period
Simple value
Exponential vaue
5D
2337.6
2304.42
10D
2282.79
2308.59
20D
2336.74
2330.47
50D
2372.55
2301.96
100D
2128.2
2151.78
Volume trend — traded volume by day
11 Sep0L
10 Sep0L
9 Sep0L
8 Sep0L
7 Sep0L
4 Sep0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
Hester Biosciences Share Price
Hester Biosciences
Pharmaceuticals
Add Stock
Add Another

Hester Biosciences Share Price FAQs

Hester Biosciences share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837